RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2 - PubMed (original) (raw)

RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2

L Waltzer et al. Nucleic Acids Res. 1995.

Free PMC article

Abstract

The Epstein-Barr virus (EBV) protein EBNA2 is a transcriptional activator that can be targeted to its DNA responsive elements by direct interaction with the cellular protein RBP-J kappa. RBP-J kappa is a ubiquitous factor, highly conserved between man, mouse and Drosophila, whose function in mammalian cells is largely unknown. Here we provide evidence that RBP-J kappa is a transcriptional repressor and, more importantly, that RBP-J kappa repression is mediated by a co-repressor. The function of the co-repressor could be counterbalanced by making a fusion protein (RBP-VP16) between RBP-J kappa and the VP16 activation domain. This RBP-VP16-mediated activation could be strongly increased by an EBNA2 protein deprived of its activation domain, but not by an EBNA2 protein incapable of making physical contact with RBP-J kappa. Our results suggest that EBNA2 activates transcription by both interfering with the function of a co-repressor recruited by RBP-J kappa and providing an activation domain.

PubMed Disclaimer

Cited by

Default repression and Notch signaling: Hairless acts as an adaptor to recruit the corepressors Groucho and dCtBP to Suppressor of Hairless.
Barolo S, Stone T, Bang AG, Posakony JW. Barolo S, et al. Genes Dev. 2002 Aug 1;16(15):1964-76. doi: 10.1101/gad.987402. Genes Dev. 2002. PMID: 12154126 Free PMC article.
The nuclear and adherent junction complex component protein ubinuclein negatively regulates the productive cycle of Epstein-Barr virus in epithelial cells.
Gruffat H, Lupo J, Morand P, Boyer V, Manet E. Gruffat H, et al. J Virol. 2011 Jan;85(2):784-94. doi: 10.1128/JVI.01397-10. Epub 2010 Nov 17. J Virol. 2011. PMID: 21084479 Free PMC article.
Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
Lan K, Kuppers DA, Verma SC, Sharma N, Murakami M, Robertson ES. Lan K, et al. J Virol. 2005 Jun;79(12):7453-65. doi: 10.1128/JVI.79.12.7453-7465.2005. J Virol. 2005. PMID: 15919901 Free PMC article.
Modulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): a novel function for the viral EBNA-LP protein.
Manet E, Polvèche H, Mure F, Mrozek-Gorska P, Roisné-Hamelin F, Hammerschmidt W, Auboeuf D, Gruffat H. Manet E, et al. Nucleic Acids Res. 2021 Oct 11;49(18):10657-10676. doi: 10.1093/nar/gkab787. Nucleic Acids Res. 2021. PMID: 34530456 Free PMC article.
Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins.
Lai EC. Lai EC. EMBO Rep. 2002 Sep;3(9):840-5. doi: 10.1093/embo-reports/kvf170. EMBO Rep. 2002. PMID: 12223465 Free PMC article. Review.

References

1. Cell. 1992 Jun 26;69(7):1199-212 - PubMed
1. Cell. 1992 Jun 26;69(7):1191-7 - PubMed
1. EMBO J. 1993 Jan;12(1):167-75 - PubMed
1. Genomics. 1993 Aug;17(2):306-15 - PubMed
1. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9237-41 - PubMed

RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2 - PubMed (original) (raw)